Northern Trust’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.98M Buy
243,395
+8,264
+4% +$67.1K ﹤0.01% 2997
2025
Q1
$1.66M Buy
235,131
+13,633
+6% +$96K ﹤0.01% 3018
2024
Q4
$1.65M Buy
221,498
+28,019
+14% +$208K ﹤0.01% 3133
2024
Q3
$954K Buy
193,479
+121,630
+169% +$600K ﹤0.01% 3378
2024
Q2
$369K Buy
71,849
+10,199
+17% +$52.3K ﹤0.01% 3616
2024
Q1
$327K Sell
61,650
-18
-0% -$96 ﹤0.01% 3715
2023
Q4
$382K Sell
61,668
-1,508
-2% -$9.34K ﹤0.01% 3637
2023
Q3
$477K Buy
63,176
+5,981
+10% +$45.1K ﹤0.01% 3533
2023
Q2
$553K Sell
57,195
-170,595
-75% -$1.65M ﹤0.01% 3521
2023
Q1
$860K Buy
227,790
+218
+0.1% +$823 ﹤0.01% 3276
2022
Q4
$1.47M Sell
227,572
-188
-0.1% -$1.22K ﹤0.01% 3135
2022
Q3
$2.03M Sell
227,760
-4,026
-2% -$35.8K ﹤0.01% 3004
2022
Q2
$2.31M Sell
231,786
-2,256
-1% -$22.5K ﹤0.01% 2976
2022
Q1
$2.71M Sell
234,042
-10,327
-4% -$120K ﹤0.01% 2943
2021
Q4
$2.71M Sell
244,369
-25,973
-10% -$288K ﹤0.01% 3066
2021
Q3
$2.49M Sell
270,342
-1,631
-0.6% -$15K ﹤0.01% 3156
2021
Q2
$3.06M Sell
271,973
-6,783
-2% -$76.3K ﹤0.01% 3140
2021
Q1
$2.96M Sell
278,756
-25,161
-8% -$267K ﹤0.01% 3044
2020
Q4
$3.3M Sell
303,917
-13,501
-4% -$147K ﹤0.01% 2923
2020
Q3
$3.09M Sell
317,418
-22,818
-7% -$222K ﹤0.01% 2828
2020
Q2
$2.71M Sell
340,236
-411
-0.1% -$3.27K ﹤0.01% 2865
2020
Q1
$2.96M Sell
340,647
-4,451
-1% -$38.7K ﹤0.01% 2625
2019
Q4
$3.9M Buy
345,098
+9,886
+3% +$112K ﹤0.01% 2733
2019
Q3
$3.64M Sell
335,212
-3,293
-1% -$35.8K ﹤0.01% 2733
2019
Q2
$3.17M Buy
338,505
+9,160
+3% +$85.8K ﹤0.01% 2806
2019
Q1
$4.05M Sell
329,345
-11,209
-3% -$138K ﹤0.01% 2675
2018
Q4
$4.03M Sell
340,554
-12,731
-4% -$151K ﹤0.01% 2637
2018
Q3
$5.09M Buy
353,285
+4,527
+1% +$65.2K ﹤0.01% 2675
2018
Q2
$5.2M Sell
348,758
-7,090
-2% -$106K ﹤0.01% 2663
2018
Q1
$4.64M Buy
355,848
+1,380
+0.4% +$18K ﹤0.01% 2634
2017
Q4
$4.47M Sell
354,468
-597
-0.2% -$7.52K ﹤0.01% 2679
2017
Q3
$4.6M Buy
355,065
+2,195
+0.6% +$28.4K ﹤0.01% 2683
2017
Q2
$5.24M Buy
352,870
+6,189
+2% +$91.9K ﹤0.01% 2612
2017
Q1
$4.16M Buy
346,681
+3,165
+0.9% +$38K ﹤0.01% 2670
2016
Q4
$4.74M Sell
343,516
-6,418
-2% -$88.6K ﹤0.01% 2576
2016
Q3
$4.69M Buy
349,934
+3,816
+1% +$51.2K ﹤0.01% 2552
2016
Q2
$3.72M Buy
346,118
+8,047
+2% +$86.6K ﹤0.01% 2658
2016
Q1
$3.57M Buy
338,071
+2,047
+0.6% +$21.6K ﹤0.01% 2632
2015
Q4
$3.98M Buy
336,024
+3,635
+1% +$43K ﹤0.01% 2601
2015
Q3
$3.88M Buy
332,389
+4,729
+1% +$55.2K ﹤0.01% 2603
2015
Q2
$4.73M Sell
327,660
-3,821
-1% -$55.1K ﹤0.01% 2556
2015
Q1
$4.62M Sell
331,481
-288
-0.1% -$4.02K ﹤0.01% 2553
2014
Q4
$4.58M Sell
331,769
-19,815
-6% -$274K ﹤0.01% 2566
2014
Q3
$4.31M Sell
351,584
-22,694
-6% -$278K ﹤0.01% 2597
2014
Q2
$4.68M Sell
374,278
-77,413
-17% -$967K ﹤0.01% 2560
2014
Q1
$5.04M Buy
451,691
+20,848
+5% +$233K ﹤0.01% 2546
2013
Q4
$5.22M Buy
430,843
+21,344
+5% +$259K ﹤0.01% 2535
2013
Q3
$5M Buy
409,499
+27,673
+7% +$338K ﹤0.01% 2507
2013
Q2
$5.04M Buy
+381,826
New +$5.04M ﹤0.01% 2411